Novel Chemical Approaches for Targeting Fusion Oncoproteins Webinar Series (Agenda)

Agenda

August 19, 12:00 pm – 1:00 pm ET

Speaker: Brandon Turunen, Ph.D., GSK

Chemical Biology Platforms to Drug the Undruggable

NCI Moderator: Sharad Verma, Ph.D.

Presentation Link: Novel Chemical Approaches for Targeting Fusion Oncoproteins 8/19/2022

August 26, 12:00 pm – 1:00 pm ET

Speaker: Angela Koehler, Ph.D., Massachusetts Institute of Technology

Attenuating Oncogenic Transcription

NCI Moderator: Malcolm Smith, M.D., Ph.D.

Presentation Link: Novel Chemical Approaches for Targeting Fusion Oncoproteins 8/26/2022 Edited (vbrick.com)

September 9, 12:00 pm – 1:00 pm ET

Speaker: John ‘Jay’ Schneekloth Jr., Ph.D., National Cancer Institute

Tools and Tactics for Targeting RNA with Small Molecules

NCI Moderator: Joel Morris, Ph.D.

Presentation Link: Novel Chemical Approaches for Targeting Fusion Oncoproteins 9/9/2022-Edited (vbrick.com)

September 16, 12:00 pm – 1:00 pm ET

Speaker: Fleur Ferguson, Ph.D., University of California San Diego

Application of Targeted Protein Degradation to Fusion Oncoproteins

NCI Moderator: Sharad Verma, Ph.D.

Presentation Link: Novel Chemical Approaches for Targeting Fusion Oncoproteins 9/16/2022 (vbrick.com)

September 23, 12:00 pm – 1:00 pm ET

Speaker: Zoran Rankovic, Ph.D., St. Jude Children’s Research Hospital

Targeted Oncoprotein Degradation for the Treatment of Pediatric Cancers

NCATS Moderator: Craig Thomas, Ph.D.

Presentation Link: Novel Chemical Approaches for Targeting Fusion Oncoproteins 9/23/2022 (vbrick.com)

September 30, 12:00 pm – 1:00 pm ET

Speaker: Huan Rui, Ph.D., Amgen

Computational Tools and Strategies for Rational Degrader Design

NCATS Moderator: Min Shen, Ph.D.

October 7, 12:00 pm – 1:00 pm ET

Speaker: Tomek Cierpicki, Ph.D., University of Michigan

Development of NSD1 inhibitors targeting NUP98-NSD1 fusion leukemia

NCI Moderator: Morgan O’Hayre, Ph.D.

October 14, 12:00 pm – 1:00 pm ET

Speaker: Matthew Disney, Ph.D., UF Scripps Biomedical Research

Ribonuclease Targeting Chimeras for the Selective Targeting of Oncogenic RNAs

NCI Moderator: Sundar Venkatachalam, Ph.D.

October 21, 12:00 pm – 1:00 pm ET

Speaker: Paul Workman, PhD, FRS, FMedSci, Institute of Cancer Research, London UK

Discovery of Clinical Cancer Drug Candidates by the Target-Based Approach and Phenotypic Screening

NCI Moderator: Beverly Teicher, Ph.D.